Nohla Therapeutics Initiates Global LAUNCH Phase 2 Trial of NLA101 in Patients with AML

World News: . []

SEATTLE Feb 13 2018 GLOBE NEWSWIRE -- Nohla Therapeutics Inc Nohla a clinical stage biopharmaceutical company focused on the development of universal, off-the-shelf cell therapies to treat cancer and other critical diseases today announc ed the ...

More news and information about Nohla Therapeutics

Published By:

Globe Newswire: 18:00 GMT Tuesday 13th February 2018

Published: .

Search for other references to "nohla" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers